Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
A critical role for extracellular protein disulfide isomerase during thrombus formation in mice
Jaehyung Cho, … , Shaun R. Coughlin, Bruce Furie
Jaehyung Cho, … , Shaun R. Coughlin, Bruce Furie
Published February 21, 2008
Citation Information: J Clin Invest. 2008;118(3):1123-1131. https://doi.org/10.1172/JCI34134.
View: Text | PDF
Research Article Article has an altmetric score of 5

A critical role for extracellular protein disulfide isomerase during thrombus formation in mice

  • Text
  • PDF
Abstract

Thiol isomerases, including protein disulfide isomerase (PDI), catalyze disulfide oxidation, reduction, and isomerization, thereby playing an important role in protein synthesis. To determine whether extracellular PDI mediates thrombus formation in an animal model, PDI expression, platelet accumulation, and fibrin generation were monitored in the blood vessels of mice by intravital fluorescence microscopy following laser-induced arteriolar injury. A time-dependent increase in PDI was observed in murine thrombi following injury. Infusion of the PDI inhibitor bacitracin or a blocking monoclonal antibody against PDI inhibited platelet thrombus formation and fibrin generation. Fibrin deposition is normal in mice lacking the G protein–coupled platelet receptor Par4, although there is no stable accumulation of platelets. Infusion of monoclonal antibodies against PDI into the circulation of Par4–/– mice prior to vessel wall injury inhibited fibrin generation. These results indicate that PDI is required in vivo in mice for both fibrin generation and platelet thrombus formation.

Authors

Jaehyung Cho, Barbara C. Furie, Shaun R. Coughlin, Bruce Furie

×

Figure 1

Interaction of anti-PDI antibodies with human and mouse PDI.

Options: View larger image (or click on image) Download as PowerPoint
Interaction of anti-PDI antibodies with human and mouse PDI.
Lysates of ...
Lysates of human (1 × 109 platelets/ml) and mouse (1 × 1010 platelets/ml) platelets were subjected to SDS gel electrophoresis followed by immunoblotting with anti-PDI antibodies. (A) Polyclonal anti-PDI antibodies. Lane 1, recombinant human PDI (20 ng); lane 2, human platelet lysate (20 μl); lane 3, mouse platelet lysate (5 μl); lane 4, mouse platelet lysate (20 μl). Left: Immunoblot developed using affinity-purified rabbit anti-bovine PDI antibody. Right: Immunoblot developed with control nonimmune IgG. (B) Monoclonal antibody RL90 to PDI. Lane 1, recombinant human PDI (1 ng); lane 2, human platelet lysate (1 μl); lane 3, mouse platelet lysate (5 μl); lane 4, mouse platelet lysate (20 μl). Left: Immunoblot developed using the RL90 anti-PDI monoclonal antibody. Right: Immunoblot developed with control IgG2a monoclonal antibody. (C) PDI activity was measured with the insulin transhydrogenase assay in the releasate of thrombin-activated mouse platelets (n = 3) in the presence or absence of 1–60 μg/ml RL90 monoclonal anti-PDI antibody (squares), 10–60 μg/ml rabbit anti-PDI antibody (inverted triangles), or 0.03–3.0 mg/ml bacitracin A (diamonds). Results are shown as a mean of 2 experiments.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 1 X users
Referenced in 7 patents
Highlighted by 1 platforms
106 readers on Mendeley
See more details